Explore
Premium
Sign Up
Log In
CRT 2017: ACS & AMI Management - ACS Pharmacotherapy
Conference
A session on ACS Pharmacotherapy from CRT 2017
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
ACS & AMI Management - ACS Pharmacotherapy
12 Expert Sessions
Featuring
Manesh Patel
Anthony Bavry
Gary Schaer
David Moliterno
Roxana Mehran
Dominick Angiolillo
Michael Lipinski
Patrick Serruys
Usman Baber
Paul Gurbel
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
ACS/PCI Guidelines and AUC Update: What Is New? - Manesh Patel
Is There A Role for Bivalirudin During PCI in Stable CAD? - Anthony Bavry
Use of Cangrelor in ACS - Case Presentations - Gary Schaer
Polypharmacy Anticoagulation - AF meets PCI
How Will PIONEER AF-PCI Change Our Practice? - Roxana Mehran
When to Switch and How to Switch Antiplatelet Therapy - Dominick Angiolillo
The Use of IIb/IIIa Inhibitors in ACS Patients - Michael Lipinski
NOACS for ACS: Is There a Role? - Roxana Mehran
Monotherapy for Stable Patients the Way to Go (Global Freedom) - Patrick Serruys
Updated North American Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI - Dominick Angiolillo
Monotherapy After 3 Months TWILIGHT (update) - Usman Baber
Is There a Role for Antiplatelet or Genetic Testing to Tailor Antiplatelet Therapy in 2017? - Paul Gurbel
Target Audience
Cardiologists
Interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons
Emergency Physicians
Physicians with an interest in Cardiovascular Innovations
Learning Objectives
Updates on ACS Pharmacology
Related Moments
Planning and guidance of complex percutaneous coronary interventions eCourse, 22nd-23rd Nov 2021
Course
22nd-23rd November 2021, 2-day course live streamed from Madrid
Supported By
CRT 2016 Technology & Innovation - Registry-based Trials and Device Benefit/Risk: Supporting Regulatory Decisions and Best Practice Guidelines
Conference
A session on Registry-based Trials and Device Benefit/Risk: Supporting Regulatory Decisions and Best Practice Guidelines at CRT 2016
The Management of Heart Failure with Preserved Ejection Fraction
Journal
Article on The Management of Heart Failure with Preserved Ejection Fraction
Loading Simple Education